2021.04.21 16:21Business

アビガン、再治験 コロナ薬承認へ追加データ―富士フイルム


2021.04.21 16:21Business

Fujifilm Unit Starts New Phase III Trial of Avigan for COVID-19

Fujifilm Toyama Chemical Co. said Wednesday that it has started a new Phase III clinical trial of its antiflu drug Avigan for use to treat COVID-19 patients in Japan.
   The Fujifilm Corp. unit applied last October for approval of Avigan as a treatment for patients with the coronavirus disease, but Japan's health ministry has found it difficult to confirm the drug's efficacy until now.